Beta Glucosylceramide for Treatment of NASH

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

December 31, 2010

Study Completion Date

December 31, 2010

Conditions

Compliance Behavior

Interventions

DRUG

Beta Glucosylceramide

DRUG

Placebo

normal saline

All Listed Sponsors

lead

Hadassah Medical Organization

OTHER

NCT02126306 - Beta Glucosylceramide for Treatment of NASH | Biotech Hunter | Biotech Hunter